Monday, June 22, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 525 of 1,261

  1. US 10172951

    Dendrimer based nanodevices for therapeutic and imaging purposes

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 8, 2019 · Expires Jan 3, 2039

    granted

  2. US 10172938

    Multimode degradable hydrogels for controlled release of cargo substances

    The Regents of the University of California · Granted Jan 8, 2019 · Expires Jan 3, 2039

    granted

  3. EP 3421496

    ANTIKÖRPER ZUR BEHANDLUNG VON CLAUDIN-6-EXPRIMIERENDEN KREBS

    GANYMED PHARMACEUTICALS GMBH [DE] · Granted Jan 2, 2019 · Expires Dec 28, 2038

    granted

  4. US 10166285

    Recombinant virus with diminished latency and methods of using same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 1, 2019 · Expires Dec 27, 2038

    granted

  5. US 10167273

    Sulfonyl piperidine derivatives and their use for treating prokineticin mediated diseases

    Takeda Pharmaceutical Company Limited · Granted Jan 1, 2019 · Expires Dec 27, 2038

    granted

  6. US 10166304

    Antibody fragments for detecting cancer and methods of use

    Regents of the University of Minnesota · Granted Jan 1, 2019 · Expires Dec 27, 2038

    granted

  7. US 10167337

    Combination immunotherapy for the treatment of cancer

    The Board of Regents of the University of Texas System · Granted Jan 1, 2019 · Expires Dec 27, 2038

    granted

  8. US 10166216

    Substituted triazoles useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Jan 1, 2019 · Expires Dec 27, 2038

    granted

  9. US 10166255

    Intracellular genomic transplant and methods of therapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 1, 2019 · Expires Dec 27, 2038

    granted

  10. US 10166257

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Jan 1, 2019 · Expires Dec 27, 2038

    granted

  11. US 10167452

    Viral purification methods

    ONCOLYTICS BIOTECH INC. · Granted Jan 1, 2019 · Expires Dec 27, 2038

    granted

  12. US 10168337

    Method and biomarkers for the detection of dengue hemorrhagic fever

    The Board of Regents of the University of Texas System · Granted Jan 1, 2019 · Expires Dec 27, 2038

    granted

  13. US 10167334

    Treatment of cancer using anti-TGF-BETA and PD-1 antibodies

    The Regents of the University of California · Granted Jan 1, 2019 · Expires Dec 27, 2038

    granted

  14. US 10167292

    Benzodiazepines as bromodomain inhibitors

    Catalyst Therapeutics Pty Ltd. · Granted Jan 1, 2019 · Expires Dec 27, 2038

    granted

  15. US 10167320

    Purification of virus like particles

    Takeda Vaccines, Inc. · Granted Jan 1, 2019 · Expires Dec 27, 2038

    granted

  16. US 10167314

    Methods of treating depression and other related diseases

    Northwestern University · Granted Jan 1, 2019 · Expires Dec 27, 2038

    granted

  17. US 10167312

    Method of treating melanocortin-4 receptor-associated disorders in heterozygous carriers

    RHYTHM PHARMACEUTICALS, INC. · Granted Jan 1, 2019 · Expires Dec 27, 2038

    granted

  18. US 10167295

    Analgesic compounds and methods of use

    The Regents of the University of California · Granted Jan 1, 2019 · Expires Dec 27, 2038

    granted

  19. US 10167263

    Treatment of amyotrophic lateral sclerosis

    Northwestern University · Granted Jan 1, 2019 · Expires Dec 27, 2038

    granted

  20. US 10167259

    Allosteric inhibitors of proteasome and methods of use thereof

    The Board of Regents of the University of Texas System · Granted Jan 1, 2019 · Expires Dec 27, 2038

    granted

  21. US 10167256

    Psychotrophic agents and uses thereof

    LB PHARMACEUTICALS INC. · Granted Jan 1, 2019 · Expires Dec 27, 2038

    granted

  22. US 10167247

    Solid forms of treprostinil

    United Therapeutics Corporation · Granted Jan 1, 2019 · Expires Dec 27, 2038

    granted

  23. US 10166299

    AAV mediated aquaporin gene transfer to treat Sjogren's syndrome

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPT. OF HEALTH AND HUMAN SERVICES OFFICE OF TECHNOLOGY TRANSFER, NATIONAL INSTITUTES OF HEALTH · Granted Jan 1, 2019 · Expires Dec 27, 2038

    granted

  24. US 10167270

    Substituted quinazoline compounds and uses thereof for modulating glucocerebrosidase activity

    Northwestern University · Granted Jan 1, 2019 · Expires Dec 27, 2038

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.